--- title: Eurofins Bioanalytical Services Blog | Clinical Trial description: Clinical Trial | --- ![Biologics Done Right](https://blog.eurofinsbioanalyticalservices.com/hs-fs/hubfs/Biologics%20Done%20Right.png?width=400&name=Biologics%20Done%20Right.png) # Eurofins Bioanalytical Services Blog ## [Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2](https://blog.eurofinsbioanalyticalservices.com/https/blog.eurofinsbioanalyticalservices.com/hs_previewcjdjtjjs-41680244318) Posted by [Kristy Galkowski](https://blog.eurofinsbioanalyticalservices.com/author/kristy-galkowski) on Feb 17, 2021 5:54:46 PM - [Tweet](https://twitter.com/share) ![Eurofins BioPharma News February 2021 FINAL WEB](https://blog.eurofinsbioanalyticalservices.com/hs-fs/hubfs/Eurofins%20BioPharma%20News%20February%202021%20FINAL%20WEB.jpg?width=169&name=Eurofins%20BioPharma%20News%20February%202021%20FINAL%20WEB.jpg) The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. Conventional neutralising antibody serological testing requires the use of a live virus conducted in a Biosafety Level 3 (BSL-3) laboratory, which presents challenges for COVID- 19 development programmes. An alternative approach is the use of a surrogate virus test (sVNT) that removes this obstacle and is the first neutralising antibody serology test to receive emergency use authorisation (EUA) from the FDA. This innovative assay detects the presence of neutralising/ blocking antibodies against the SARS-CoV-2 virus, that block the interaction between the receptor-binding domain (RBD) of the viral spike glycoprotein and the ACE2 cell surface receptor. Current testing methods, such as PCR, determine whether someone is actively infected by confirming the presence of viral material or IgG/IgM antibodies that detect (binding and blocking) induced immune response from exposure to the virus. Being an ELISA methodology, the in-house, fully validated surrogate virus neutralisation test (sVNT) is amenable to high-throughput testing, at a lower analytical cost, and requires no extended validation timelines for Eurofins’ client base. It also removes the obstacle faced by many COVID-19 development programmes, by eliminating the requirement for a Biosafety level 3 containment. The advantage over historic antibody IgG/IgM tests is that this new gold standard assay tests for neutralising antibodies (versus binding antibodies), by confirming neutralising function without the need for a secondary antibody and is isotype and species independent. As the world strives to combat the COVID-19 pandemic, Eurofins is committed to being part of global solution by expanding capacity to develop reagent kits and investments in nonproprietary assays to offer for industry COVID-19 analytical Nab testing. For More Information on the latest Eurofins News, please [click here](http://info.eurofinscentrallaboratory.com/download-the-ebps-newsletter) [Read More](https://blog.eurofinsbioanalyticalservices.com/https/blog.eurofinsbioanalyticalservices.com/hs_previewcjdjtjjs-41680244318) 0 Comments [Click here to read/write comments](https://blog.eurofinsbioanalyticalservices.com/https/blog.eurofinsbioanalyticalservices.com/hs_previewcjdjtjjs-41680244318#comments-listing) Tags: [Quality](https://blog.eurofinsbioanalyticalservices.com/tag/quality), [Clinical Trial](https://blog.eurofinsbioanalyticalservices.com/tag/clinical-trial), [Bioanalytical Testing](https://blog.eurofinsbioanalyticalservices.com/tag/bioanalytical-testing), [Pharmaceutical](https://blog.eurofinsbioanalyticalservices.com/tag/pharmaceutical), [Development](https://blog.eurofinsbioanalyticalservices.com/tag/development), [Immunology](https://blog.eurofinsbioanalyticalservices.com/tag/immunology), [SARS-CoV-2](https://blog.eurofinsbioanalyticalservices.com/tag/sars-cov-2), [neutralizing antibody testing](https://blog.eurofinsbioanalyticalservices.com/tag/neutralizing-antibody-testing) ## [Join Us for the 2019 DIA Annual Meeting in San Diego, CA](https://blog.eurofinsbioanalyticalservices.com/join-us-for-the-2019-dia-annual-meeting-in-san-diego-ca) Posted by [Jesse Gehris](https://blog.eurofinsbioanalyticalservices.com/author/jesse-gehris) on Jun 3, 2019 9:15:00 AM - [Tweet](https://twitter.com/share) [![f4gcOn_w](https://blog.eurofinsbioanalyticalservices.com/hubfs/f4gcOn_w.jpeg)](https://blog.eurofinsbioanalyticalservices.com/join-us-for-the-2019-dia-annual-meeting-in-san-diego-ca)   [Read More](https://blog.eurofinsbioanalyticalservices.com/join-us-for-the-2019-dia-annual-meeting-in-san-diego-ca) 0 Comments [Click here to read/write comments](https://blog.eurofinsbioanalyticalservices.com/join-us-for-the-2019-dia-annual-meeting-in-san-diego-ca#comments-listing) Tags: [Central Laboratory](https://blog.eurofinsbioanalyticalservices.com/tag/central-laboratory), [Quality](https://blog.eurofinsbioanalyticalservices.com/tag/quality), [Clinical Trial](https://blog.eurofinsbioanalyticalservices.com/tag/clinical-trial), [Drug Development](https://blog.eurofinsbioanalyticalservices.com/tag/drug-development), [Bioanalytical Testing](https://blog.eurofinsbioanalyticalservices.com/tag/bioanalytical-testing), [Development](https://blog.eurofinsbioanalyticalservices.com/tag/development), [BioPharma](https://blog.eurofinsbioanalyticalservices.com/tag/biopharma), [Gene Therapy](https://blog.eurofinsbioanalyticalservices.com/tag/gene-therapy) ## [Join Eurofins at the 2019 BIO Annual International Convention](https://blog.eurofinsbioanalyticalservices.com/join-eurofins-at-the-2019-bio-annual-international-convention) Posted by [Jesse Gehris](https://blog.eurofinsbioanalyticalservices.com/author/jesse-gehris) on May 10, 2019 9:00:00 AM - [Tweet](https://twitter.com/share) [![](https://blog.eurofinsbioanalyticalservices.com/hubfs/EurofinsCentralLaboratory%20-Jan2018/Images/Banner.jpg)](https://blog.eurofinsbioanalyticalservices.com/join-eurofins-at-the-2019-bio-annual-international-convention) [Eurofins BioPharma Services](https://www.linkedin.com/showcase/eurofins-pharma/) will be attending the 2019 BIO International Convention in Philadelphia, June 3-6, to celebrate the **globally important innovations in biotech that start with one:** one meeting, one theory, one trial, one breakthrough. Join [Eurofins BioPharma Services](https://www.linkedin.com/showcase/eurofins-pharma/) at Booth 2949 to consider how the largest wholly-owned network of BioPharma dedicated laboratories in the world can assist in your clinical trial research! [Read More](https://blog.eurofinsbioanalyticalservices.com/join-eurofins-at-the-2019-bio-annual-international-convention) 0 Comments [Click here to read/write comments](https://blog.eurofinsbioanalyticalservices.com/join-eurofins-at-the-2019-bio-annual-international-convention#comments-listing) Tags: [Central Laboratory](https://blog.eurofinsbioanalyticalservices.com/tag/central-laboratory), [Quality](https://blog.eurofinsbioanalyticalservices.com/tag/quality), [Results](https://blog.eurofinsbioanalyticalservices.com/tag/results), [Clinical Trial](https://blog.eurofinsbioanalyticalservices.com/tag/clinical-trial), [BioPharma](https://blog.eurofinsbioanalyticalservices.com/tag/biopharma) [All posts](https://blog.eurofinsbioanalyticalservices.com/all) ## Global Leader in Biologics-focused Bioanalytical Solutions ### Stay in the know and up-to-date on the latest Bioanalytical news, tips, and helpful links - Gain insight into the latest technology in the field - Focus on clinical research and laboratory services - Learn more about Biologics done right ### Subscribe to Email Updates ### Recent Posts ### Posts by Topic - [BioPharma (7)](https://blog.eurofinsbioanalyticalservices.com/tag/biopharma) - [Bioanalytical Testing (7)](https://blog.eurofinsbioanalyticalservices.com/tag/bioanalytical-testing) - [Development (6)](https://blog.eurofinsbioanalyticalservices.com/tag/development) - [Quality (4)](https://blog.eurofinsbioanalyticalservices.com/tag/quality) - [Clinical Trial (3)](https://blog.eurofinsbioanalyticalservices.com/tag/clinical-trial) - [Drug Development (3)](https://blog.eurofinsbioanalyticalservices.com/tag/drug-development) - [Flow Cytometry (3)](https://blog.eurofinsbioanalyticalservices.com/tag/flow-cytometry) - [Immunology (3)](https://blog.eurofinsbioanalyticalservices.com/tag/immunology) - [Central Laboratory (2)](https://blog.eurofinsbioanalyticalservices.com/tag/central-laboratory) - [Results (2)](https://blog.eurofinsbioanalyticalservices.com/tag/results) - [Technology (2)](https://blog.eurofinsbioanalyticalservices.com/tag/technology) - [Biomarker Analysis (1)](https://blog.eurofinsbioanalyticalservices.com/tag/biomarker-analysis) - [CRO (1)](https://blog.eurofinsbioanalyticalservices.com/tag/cro) - [Cellular Response (1)](https://blog.eurofinsbioanalyticalservices.com/tag/cellular-response) - [Gene Therapy (1)](https://blog.eurofinsbioanalyticalservices.com/tag/gene-therapy) - [Immune Cell Function (1)](https://blog.eurofinsbioanalyticalservices.com/tag/immune-cell-function) - [Immunogenecity (1)](https://blog.eurofinsbioanalyticalservices.com/tag/immunogenecity) - [Leadership (1)](https://blog.eurofinsbioanalyticalservices.com/tag/leadership) - [Pharmaceutical (1)](https://blog.eurofinsbioanalyticalservices.com/tag/pharmaceutical) - [Quanterix (1)](https://blog.eurofinsbioanalyticalservices.com/tag/quanterix) - [Receptor Engagement (1)](https://blog.eurofinsbioanalyticalservices.com/tag/receptor-engagement) - [SARS-CoV-2 (1)](https://blog.eurofinsbioanalyticalservices.com/tag/sars-cov-2) - [neutralizing antibody testing (1)](https://blog.eurofinsbioanalyticalservices.com/tag/neutralizing-antibody-testing) see all Eurofins Bioanalytical Services | | (844) 522-7787 | | [bioanalyticalinfo@eurofins.com](mailto:bioanalyticalinfo@eurofins.com)